Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing and delivering innovative products to patients suffering from debilitating diseases such as lupus nephritis (LN).

How We’re Helping Patients

Latest News

April 20, 2017 • 12:00am EDT

Aurinia Releases Additional 48-Week Data from the AURA-LV Study During Late-Breaking Session at the National Kidney Foundation 2017 Spring Clinical Meetings

Read Press Release View All News

April 17, 2017 • 12:00am EDT

Aurinia Completes Licensing Deal with Merck Animal Health for Its Nanomicellar Formulation of Voclosporin for the Treatment of Canine Dry Eye Syndrome

Read Press Release View All News

April 10, 2017 • 12:00am EDT

Aurinia to Host Investor Event and Webcast on April 20th in Orlando, FL

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today